Log in to save to my catalogue

Posttransplant cyclophosphamide after allogeneic hematopoietic cell transplantation mitigates the im...

Posttransplant cyclophosphamide after allogeneic hematopoietic cell transplantation mitigates the im...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A650886444

Posttransplant cyclophosphamide after allogeneic hematopoietic cell transplantation mitigates the immune activation induced by previous nivolumab therapy

About this item

Full title

Posttransplant cyclophosphamide after allogeneic hematopoietic cell transplantation mitigates the immune activation induced by previous nivolumab therapy

Publisher

Nature Publishing Group

Journal title

Leukemia, 2020, Vol.34 (12), p.3420

Language

English

Formats

Publication information

Publisher

Nature Publishing Group

More information

Alternative Titles

Full title

Posttransplant cyclophosphamide after allogeneic hematopoietic cell transplantation mitigates the immune activation induced by previous nivolumab therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A650886444

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A650886444

Other Identifiers

ISSN

0887-6924

DOI

10.1038/s41375-020-0851-8

How to access this item